Overexpression of FAP on activated CAF within the tumor microenvironment occurs in ~90% of epithelial malignancies, including breast, ovarian, lung and colorectal cancer, supporting FAP as a pan-cancer theranostic target 92. This evidence concerns the gene FAP and neoplasm.